Expand JBIO Menu
JBIO MENU

JBIO Latest Press Releases

-- June 26, 2026 --

Jade Biosciences Announces Appointment of Mark Eisner, M.D., M.P.H., to Board of Directors Globe Newswire 7:00 AM

-- June 5, 2026 --

Jade Biosciences Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares Globe Newswire 4:01 PM

-- June 3, 2026 --

Jade Biosciences Announces Pricing of Public Offering of Common Stock Globe Newswire 10:58 PM
Jade Biosciences Announces Proposed Underwritten Public Offering Globe Newswire 4:01 PM

-- June 1, 2026 --

Jade Biosciences Announces Positive Interim Phase 1 Results for JADE101 Demonstrating Potential Best-in-Class Profile and Every-12-Week Dosing in IgA Nephropathy Globe Newswire 7:00 AM

-- May 29, 2026 --

Jade Biosciences to Host Conference Call and Webcast on June 1, 2026, at 8:00 a.m. ET to Discuss Interim Phase 1 Healthy Volunteer Results for JADE101, a Novel, Potentially Best-in-Class Anti-APRIL Monoclonal Antibody in Development for IgA Nephropathy Globe Newswire 4:05 PM

-- May 26, 2026 --

Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody Globe Newswire 4:05 PM
Jade Biosciences Announces First Participant Dosed in Phase 2 JUNIPER Clinical Trial of JADE101 in IgA Nephropathy Globe Newswire 7:00 AM

-- May 7, 2026 --

Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 4:05 PM

-- April 23, 2026 --

Jade Biosciences Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 7:00 AM

-- April 22, 2026 --

Jade Biosciences Appoints Edward R. Conner, M.D., as Chief Medical Officer Globe Newswire 7:00 AM

-- March 6, 2026 --

Jade Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update Globe Newswire 7:00 AM

-- February 11, 2026 --

Jade Biosciences to Participate in Upcoming Conferences Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes